Hyper IgM Foundation Offers Seed Grant Funding
The Hyper IgM Foundation is proud to announce the availability of seed grant funding for researchers interested in the advancement of a cure for Hyper IgM Syndrome. The intent of these grants is to accelerate scientific work focused on improving the treatment, quality of life, and long-term outlook for patients with Hyper IgM. Special consideration will be given to well-defined projects focused on gene therapy/editing for CD40 Ligand Deficiency as well as hematopoietic stem cell transplantation for CD40 Ligand Deficiency.
During the calendar years 2017 and 2018, the Hyper IgM Foundation will be awarding one-time grants of up to $5,000 to worthy recipients each year. The 2017 Grant recipients may be eligible for an additional one-time grant of up to $5,000 in 2018. Grant applications will be considered twice per year with next submission deadline of September 30th, 2017.